trial · primary record
Zasocitinib
Nonsegmental Vitiligo
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 200 |
| Primary completion | 2027-11-09 |
| Primary endpoint | Percentage of Participants Achieving >= 75% Improvement From Baseline in Facial Vitiligo Area Scoring Index (F-VASI) at Week 24 |
| Registry ID | NCT07108283 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:45:06.459Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07108283
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.